Brandon BioCatalyst invests in opportunities that are associated with our Member Institutes.
Brandon BioCatalyst is interested in opportunities covering the full spectrum of biomedical development, from proof-of-concept opportunities through to late-stage technologies. We can provide investment of as little as AU$500,000, or up to AU$30 million in funding, depending on the stage of development and funding requirements.
Every Member has a representative on the Investment Review Committee (IRC). The Institute representative will present a brief overview of the investment opportunity to the IRC (Preliminary Investment Proposal-PIP).
If this initial proposal is recommended to progress, a presentation by the key researchers accompanied by a full investment proposal (Investment Application Form – IAF) will be requested for the next IRC meeting.
If the IRC is supportive of the technology progressing, the opportunity is then passed to Brandon Capital to complete due diligence and agree the development and commercialisation plan and funding needs.
If Brandon Capital is supportive of the opportunity, it then recommends to the Board that the investment is made. The Board facilitates the calling of capital. Guidance and assistance is provided by Brandon Capital for the preparation of both the initial and full investment proposals. Please see the ‘Contact Us’ page for contact information.